Hospital
Community Hospital of Andalusia LLC
Community Hospital of Andalusia LLC was paid $2.27M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.
33Billing provider infoCOMMUNITY HOSPITAL OF ANDALUSIA LLC
ANDALUSIA, AL 36420
ANDALUSIA, AL 36420
33aNPI1821078494assigned 01/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.27M
24GClaims104,066
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#30 of 77
Median peer was paid$1.13M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TEAGUE, KATHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,817 | $361K | |
| 2019 | 15,732 | $344K | |
| 2020 | 9,706 | $217K | |
| 2021 | 13,423 | $280K | |
| 2022 | 15,107 | $305K | |
| 2023 | 20,828 | $510K | |
| 2024incomplete | 9,453 | $259K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 20,770 | 18,734 | $728K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 11,558 | 9,795 | $610K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 1,337 | 1,018 | $283K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.6% | 8,299 | 4,198 | $105K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 2,323 | 2,214 | $86K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 12,090 | 9,716 | $82K |
| 87430 | 2.6% | 3,792 | 3,546 | $59K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 1,668 | 1,516 | $42K |
| 80053 | Comprehensive metabolic panel | 1.8% | 5,164 | 4,056 | $42K |
| 87081 | 1.2% | 2,721 | 2,557 | $27K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,538 | 303 | $21K |
| 81001 | <1% | 5,326 | 4,381 | $17K |
80 more codes
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 134 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,111 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 331 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 304 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 195 | $10K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,238 | $9K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 72 | $9K |
| 87420 | <1% | 517 | $9K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 148 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,097 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 827 | $7K |
| 83735 | <1% | 1,200 | $6K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 298 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 621 | $5K |
| 59025 | Fetal non-stress test | <1% | 1,010 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 229 | $3K |
| 84484 | <1% | 662 | $3K | |
| 81025 | <1% | 834 | $2K | |
| 87634 | <1% | 37 | $2K | |
| 83690 | <1% | 453 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 192 | $2K |
| 81003 | <1% | 909 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 17 | $2K |
| 80061 | Lipid panel | <1% | 127 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,520 | $2K |
| 82607 | <1% | 110 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 103 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 407 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 181 | $1K |
| 86140 | <1% | 428 | $951.06 | |
| 82746 | <1% | 66 | $839.96 | |
| 86376 | <1% | 44 | $737.88 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 17 | $625.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,937 | $596.50 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 98 | $576.18 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 62 | $542.50 |
| 84403 | <1% | 13 | $498.63 | |
| 83655 | <1% | 29 | $452.10 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $384.36 |
| 80076 | <1% | 87 | $376.20 | |
| 82553 | <1% | 95 | $340.20 | |
| 82248 | <1% | 115 | $329.85 | |
| 82728 | <1% | 28 | $266.40 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 383 | $251.86 |
| 85027 | <1% | 134 | $251.76 | |
| 84479 | <1% | 43 | $233.97 | |
| 82550 | <1% | 96 | $201.60 | |
| 84436 | <1% | 43 | $175.23 | |
| 83605 | <1% | 15 | $148.00 | |
| 86038 | <1% | 15 | $134.56 | |
| 85651 | <1% | 39 | $104.40 | |
| 87077 | <1% | 19 | $98.78 | |
| 82247 | <1% | 30 | $87.30 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 27 | $81.60 |
| 84460 | <1% | 13 | $66.51 | |
| 85007 | <1% | 13 | $65.91 | |
| 84450 | <1% | 13 | $60.48 | |
| 93017 | <1% | 12 | $56.12 | |
| 85018 | <1% | 15 | $52.05 | |
| 85014 | <1% | 15 | $52.05 | |
| 85652 | <1% | 29 | $51.61 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 634 | $51.24 |
| 86850 | <1% | 31 | $34.98 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 29 | $27.90 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,833 | $19.36 |
| 86900 | <1% | 32 | $16.31 | |
| 86901 | <1% | 32 | $16.16 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 853 | $2.61 |
| J2704 | Injection, propofol, 10 mg | <1% | 176 | $0.44 |
| A9270 | Non-covered item or service | 0% | 638 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 170 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 76 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 18 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 65 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 840 | $0.00 |
| C1780 | Lens, intraocular (new technology) | 0% | 72 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 34 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 17 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 34 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEAGUE, KATHY (VICE PRESIDENT, CORPORATE SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| Rchp-Wilmington, LLC | Wilmington, OH | $13.53M |
| Providence Hospital, LLC | Columbia, SC | $12.68M |
| Vaughan Regional Medical Center LLC | Selma, AL | $8.15M |
| Kershaw Hospital LLC | Camden, SC | $7.93M |
| Bolivar Physician Practices LLC | Cleveland, MS | $3.05M |
| Wilmington Physicians Group LLC | Wilmington, OH | $3.04M |
| Phc-Morgan City LP | Morgan City, LA | $2.37M |
| Vaughan Regional Medical Center LLC | Marion, AL | $2.15M |
| PRHC Ennis LP | Ennis, TX | $1.81M |
| Andalusia Physician Practices LLC | Andalusia, AL | $847K |
| Meadowview Physician Practice LLC | Maysville, KY | $783K |
| Logan Physician Practice LLC | Auburn, KY | $458K |
| Logan Physician Practice LLC | Russellville, KY | $317K |
| Kentucky Mso LLC | Georgetown, KY | $248K |
| Rchp-Wilmington, LLC | Wilmington, OH | $165K |
| Meadowview Physician Practice LLC | Maysville, KY | $140K |
| Amg-Southern Tennessee LLC | Monteagle, TN | $136K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $135K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $57K |
| Kershaw Hospital LLC | Lugoff, SC | $49K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.